Evidence map›Paper›PMID 34346740›Full record

ArticleCirculation2021

hiPSC Modeling of Lineage-Specific Smooth Muscle Cell Defects Caused by

Dong Zhou, Hao Feng, Ying Yang, Tingting Huang, Ping Qiu, Chengxin Zhang, Timothy R Olsen, Jifeng Zhang, Y Eugene Chen, Dogukan Mizrak and 1 more

Open access · greenAbstract read
In one paragraph

Article in Circulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  17. Review
  18. Article
  19. Review
  20. Bioengineered vascular grafts with a pathogenicScience translational medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Dong Zhou *Department of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.
Hao Feng *Department of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.
Ying YangDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.ORCID 0000-0003-2378-6889
Tingting HuangDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.
Ping QiuDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.
Chengxin ZhangDepartment of Computational Medicine and Bioinformatics (C.Z.), University of Michigan, Ann Arbor.
Timothy R OlsenDepartment of Systems Biology, Columbia University, New York (T.R.O.).
Jifeng ZhangDepartment of Internal Medicine (J.Z., Y.E.C.), University of Michigan, Ann Arbor.
Y Eugene ChenDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.ORCID 0000-0002-9885-9686
Dogukan MizrakDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.ORCID 0000-0002-9885-9686
Bo YangDepartment of Cardiac Surgery (D.Z., H.F., Y.Y., T.H., P.Q., Y.E.C., D.M., B.Y.), University of Michigan, Ann Arbor.ORCID 0000-0002-2158-9155
University of Michigan · USCentral South University · CNNew York Times · US

Funding

Using genetics to discover mechanisms of myocardial infarctionR01HL109946 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YUQING Eugene CHEN, Ida Liisa Surakka · 2011 to 2026
$8.9M
KLF14 and Cardiovascular DiseaseR01HL134569 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2017 to 2024
$5.3M
Therapeutic Insights into Loeys-Dietz Syndrome using Humanized ModelsR01HL151776 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bo Yang · 2020 to 2026
$4.2M
Define the mechanisms of aortopathy in bicuspid aortic valve patientsR01HL141891 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, BO · 2018 to 2022
$3.5M
Two-stage miRNA delivering scaffolds for patient-originated cells to regenerate blood vesselsR01HL136231 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2017 to 2020
$3.0M
Kruppel-like factor 11 (KLF11) and atherosclerosisR01HL138139 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHANG, JIFENG · 2017 to 2021
$2.3M
Effect of mutations in the TGF-beta pathway genes on smooth muscle cell differentiation using patient derived iPSCs.K08HL130614 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YANG, BO · 2016 to 2020
$848k
NHLBI NIH HHS K08 HL130614NHLBI NIH HHS R01 HL109946NHLBI NIH HHS R01 HL134569NHLBI NIH HHS R01 HL136231NHLBI NIH HHS R01 HL138139NHLBI NIH HHS R01 HL141891NHLBI NIH HHS R01 HL151776
6 · The paper itself

Abstract

backgroundLoeys-Dietz syndrome (LDS) is an inherited disorder predisposing individuals to thoracic aortic aneurysm and dissection. Currently, there are no medical treatments except surgical resection. Although the genetic basis of LDS is well-understood, molecular mechanisms underlying the disease remain elusive, impeding the development of a therapeutic strategy. In addition, aortic smooth muscle cells (SMCs) have heterogenous embryonic origins, depending on their spatial location, and lineage-specific effects of pathogenic variants on SMC function, likely causing regionally constrained LDS manifestations, have been unexplored.

methodsWe identified an LDS family with a dominant pathogenic variant in the

resultsOur results indicate the

conclusionsThis study reveals that a pathogenic

Indexed as

HumansInduced Pluripotent Stem CellsLoeys-Dietz SyndromeReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type ITGFBR1 protein, humanactivinshiPSCLoeys-Dietz syndromerapamycinRNA sequencingsmooth muscle cellsTGFBR1

Identifiers

PMID34346740
PMCPMC8681699
OpenAlexW3192340087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.